Please use this identifier to cite or link to this item: https://doi.org/10.1038/ncomms12983
Title: Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity
Authors: Ooi, W.F
Xing, M
Xu, C 
Yao, X
Ramlee, M.K
Lim, M.C 
Cao, F 
Lim, K 
Babu, D 
Poon, L.-F 
Lin Suling, J
Qamra, A 
Irwanto, A
Qu Zhengzhong, J
Nandi, T
Lee-Lim, A.P
Chan, Y.S
Tay, S.T 
Lee, M.H 
Davies, J.O.J
Wong, W.K
Soo, K.C 
Chan, W.H 
Ong, H.S 
Chow, P 
Wong, C.Y 
Rha, S.Y
Liu, J
Hillmer, A.M
Hughes, J.R
Rozen, S 
Teh, B.T 
Fullwood, M.J 
Li, S 
Tan, P 
Keywords: hepatocyte nuclear factor 4alpha
transcription factor Cdx2
cancer
cells and cell components
chromosome
gene expression
genetic analysis
genomics
heterogeneity
mortality
tumor
Article
cancer susceptibility
cell interaction
chromatin
controlled study
enhancer region
epigenetics
gene expression
genetic heterogeneity
genetic risk
histone modification
human
human cell
human tissue
primary tumor
single nucleotide polymorphism
stomach adenocarcinoma
Issue Date: 2016
Publisher: Nature Publishing Group
Citation: Ooi, W.F, Xing, M, Xu, C, Yao, X, Ramlee, M.K, Lim, M.C, Cao, F, Lim, K, Babu, D, Poon, L.-F, Lin Suling, J, Qamra, A, Irwanto, A, Qu Zhengzhong, J, Nandi, T, Lee-Lim, A.P, Chan, Y.S, Tay, S.T, Lee, M.H, Davies, J.O.J, Wong, W.K, Soo, K.C, Chan, W.H, Ong, H.S, Chow, P, Wong, C.Y, Rha, S.Y, Liu, J, Hillmer, A.M, Hughes, J.R, Rozen, S, Teh, B.T, Fullwood, M.J, Li, S, Tan, P (2016). Epigenomic profiling of primary gastric adenocarcinoma reveals super-enhancer heterogeneity. Nature Communications 7 : 12983. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms12983
Abstract: Regulatory enhancer elements in solid tumours remain poorly characterized. Here we apply micro-scale chromatin profiling to survey the distal enhancer landscape of primary gastric adenocarcinoma (GC), a leading cause of global cancer mortality. Integrating 110 epigenomic profiles from primary GCs, normal gastric tissues and cell lines, we highlight 36,973 predicted enhancers and 3,759 predicted super-enhancers respectively. Cell-line-defined super-enhancers can be subclassified by their somatic alteration status into somatic gain, loss and unaltered categories, each displaying distinct epigenetic, transcriptional and pathway enrichments. Somatic gain super-enhancers are associated with complex chromatin interaction profiles, expression patterns correlated with patient outcome and dense co-occupancy of the transcription factors CDX2 and HNF4?. Somatic super-enhancers are also enriched in genetic risk SNPs associated with cancer predisposition. Our results reveal a genome-wide reprogramming of the GC enhancer and super-enhancer landscape during tumorigenesis, contributing to dysregulated local and regional cancer gene expression. © 2016 The Author(s).
Source Title: Nature Communications
URI: https://scholarbank.nus.edu.sg/handle/10635/174932
ISSN: 20411723
DOI: 10.1038/ncomms12983
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_ncomms12983.pdf3.98 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.